Title : Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.

Pub. Date : 2011 Feb

PMID : 21403839






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis. Sulindac catenin (cadherin associated protein), beta 1 Mus musculus
2 We treated colon cancer cell lines heterozygous for gain-of-function and wild-type beta-catenin with sulindac. Sulindac catenin (cadherin associated protein), beta 1 Mus musculus
3 We report the expression knockdown of beta-catenin by sulindac, leading to its reduced nuclear accumulation. Sulindac catenin (cadherin associated protein), beta 1 Mus musculus
4 Splenic tumors and liver metastases of sulindac-treated mice showed lowered beta-catenin and S100A4 levels. Sulindac catenin (cadherin associated protein), beta 1 Mus musculus
5 These results suggest that modulators of beta-catenin signaling such as sulindac offer potential as antimetastatic agents by interdicting S100A4 expression. Sulindac catenin (cadherin associated protein), beta 1 Mus musculus